cll treatment: novel agents vs. cellular therapies
Published 5 years ago • 45 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
1:17
the evolution of frontline treatment for cll: from chemoimmunotherapy to targeted agents
-
2:12
can chemoimmunotherapy in cll treatment be replaced with novel agents?
-
1:22
protacs: potential novel agents for the treatment of cll
-
1:19
cll treatment: a look into the future
-
2:36
novel non-immunological agents currently under investigation for cll
-
1:31
novel approaches to cll treatment
-
1:31
frontline treatment for cll: the changing paradigm
-
2:00
associated toxicities of novel therapies for cll
-
6:43
key highlights in cll: clinical trial updates & the role of combination therapies and novel btkis
-
6:54
biomarker-guided treatment of cll in the chemo-free era
-
4:34
arthur's story: his cll diagnosis. challenges, treatments and future hope.
-
3:51
the role of frontline chemoimmunotherapy in the era of novel agents in cll
-
0:51
novel therapies in the future of cll treatment
-
1:28
the future of cll treatment
-
2:09
novel agents in cll: could they make chemotherapy redundant?
-
1:55
novel agents in cll: the importance of affordability
-
2:36
transplantation versus novel therapies in high-risk chronic lymphoblastic leukemia (cll)?
-
1:32
novel agent combinations: the future of cll
-
2:14
novel approaches to first line cll treatment
-
3:00
how do novel agents affect allogeneic transplantation in cll?
-
0:53
the future of cll treatment
-
1:18
advances in cll treatment